NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Anivance AI

Anivance AI

Private
TaiwanHealthcare & Life Scienceshttps://anivance.io/

Last Round

Seed

Nov 30, 2024

Total Funding Raised

$2.23M

Company Overview

Anivance AI is a biotechnology company that develops AI-enabled organ-on-chip and microphysiological systems to generate human-relevant preclinical data for drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical Devices, Medical AI, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Infrastructure

Keywords

organ-on-chipOoCmicrophysiological systemsMPSpreclinical drug discoveryanimal-free testingNAMsnew approach methodologieslab-as-a-serviceLaaSAI-driven automationphysical AImicrofluidicstoxicity predictionin vitro modelsdrug development platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anivance AI Comps

Public and private peers based on sector, stage, and business model.

Anivance AI comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Anivance AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 30, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Guan-Yu Chen

CEO, Founder

Founding Team

Jia-Wei Yang

Chief Operating Officer, Scientist

Executive Team

Anivance AI Investors

Notable investors and investment history

Anivance AI investors
InvestorRounds
Plug and Play Tech CenterAccelerator
BE AcceleratorAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 24, 2025

    Grew 67% QoQ, from 12 to 20 employees.

  • Jun 7, 2025

    Grew 30% QoQ, from 10 to 13 employees.

View all signals

Anivance AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anivance AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anivance AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersTaiwan
Employee Range24
Year Founded2021
Last FundingNov 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.